Search Results for “Research” - Page 10

Antabuse moves into clinical trial for people with RP

Disulfiram (Antabuse), FDA-approved for deterring alcohol, is in a phase 1 trial at the University of Washington to improve vision in retinitis pigmentosa.

First patient receives ground-breaking treatment

In January 23-year-old Jake Ternent became the first person with an inherited sight loss condition to be treated in the UK with Luxturna (voretigene neparvovec) for Leber congenital amaurosis (LCA).

A machine with a digital display with a hand in a green glove pressing the screen with their index finger

Therapy development updates

There are many ongoing clinical and laboratory studies around the world, exploring innovative approaches to treating inherited sight loss.

News

Significantly worse vision found in female carriers of X-linked RP and Choroideremia

It was previously believed that female carriers of X-linked inherited retinal diseases (IRDs) like X-linked retinitis pigmentosa (RP and Choroideremia) remained unaffected by sight loss.

SB-007, we’ve been expecting you

Introducing Splice Bio, a genetic medicines company with some exciting developments for Stargardt’s patients.

The cover of the Summer 2022 edition of Look Forward

Look Forward – Summer 2022 – Issue 177

We’re all still buzzing from our recent conferences. We do hope you enjoyed them as much as we did. If you weren’t able to join us, then you can watch or listen to the recordings on our website.

A man wearing a red checked shirt standing at a lectern in front of a number of seated people

The Gene Team

Funding from Retina UK has allowed to team to explore the viability of gene therapy as a treatment for RP and related conditions, and build a pipeline of clinical trials.